Emmes is proud to be part of the American Academy of Ophthalmology 2025 Annual Meeting in Orlando! 🎉 With 35+ years of expertise in ophthalmology trials, we deliver innovation, AI-driven solutions, and trusted experience across studies in AMD, diabetic retinopathy, ophthalmic devices, and gene therapy. Shaping the future of eye care — together. 👁️ Join us at Booth #1006 to discover how Emmes is shaping the future of eye care through innovation and expertise. #AAO2025 #Ophthalmology #ClinicalResearch #InnovationInSight #Emmes #CRO
About us
For over 40 years, our team of 1,000+ experienced professionals have provided the full range of Contract Research Organization expertise necessary to conduct clinical research with a firm scientific basis that is fully compliant with national and international regulatory guidelines. With offices throughout the US, Europe, Canada, and India, Emmes supports the advancement of global public health and biopharmaceutical innovation through disciplined science, rigorous research, fact-based decision-making, and operational excellence. Emmes possesses knowledge across a broad range of therapeutic areas, with specializations in Vaccines and Infectious Diseases, Ophthalmology, Immunology and Neuroscience. From comprehensive support of pandemic research to groundbreaking work in cell and gene therapy across the globe, Emmes has collaborated on clinical research across a wide array of disease states in over 75 nations. As a strategic collaborator with applied talent in over 2,000 clinical trials and contributions to over 2,500 publications that advance the understanding of medicine and public health, Emmes is committed to expanding the services offered to best meet the changing needs of clients and studies. Ongoing investments in global clinical research capabilities, innovative data management platforms, biostatistics/bioinformatics expertise, and people have enabled Emmes to provide a multi-faceted approach to help you meet your research objectives. Emmes is a diverse, inclusive, innovative CRO that values integrity, agility, passion for excellence, collaborative partnerships, and intellectual curiosity.
- Website
-
http://www.emmes.com
External link for Emmes
- Industry
- Research Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Rockville, MD
- Type
- Privately Held
Locations
Employees at Emmes
Updates
-
Emmes reposted this
🌍 VaxTrials, part of Emmes Group is headed to The World Vaccine Congress in Amsterdam, October 13-16. We’re excited to connect with global vaccine development leaders and share how VaxTrials, part of Emmes Group is driving innovation in vaccine research. If you’ll be at #WVCEurope, let’s connect! Drop us a message or stop by booth #412! 👉 Stay tuned for more updates as we count down to #WVCEurope. #WVCEurope #Vaccines #VaccineDevelopment #ClinicalResearch #ClinicalTrials #LifeSciences #InnovationInHealthcare #GlobalHealth #VaxTrials
-
-
The Emmes ophthalmology team is heading to EU Retina! With 35+ years of ophthalmic expertise, we’re proud to be a trusted CRO partner driving innovation in clinical research. Let’s connect in Paris and explore how Emmes is advancing ophthalmology through data, technology, and deep scientific expertise. #EmmesGroup #EURetina #Ophthalmology #ClinicalTrials #AdvancingVision
-
-
Rare ophthalmology trials demand more than science — they require innovation. From scarce patient populations to complex imaging and outcome measures, every step is a challenge. Our latest infographic highlights five key challenges in designing and running these trials — and how Emmes helps sponsors overcome them through strategic planning and collaboration, bringing new hope to patients. Visit us to learn more: https://lnkd.in/eR9G7wiV #Ophthalmology #RareDiseases #ClinicalTrials #EmmesGroup #Emmes
-
Emmes reposted this
Last week, Emmes India celebrated the nation’s 79th Independence Day with colleagues from our Bangalore office and remote teams. The occasion was observed with a spirit of unity and patriotism, symbolized through tricolor attire, engaging activities, and shared camaraderie. We remain committed to advancing healthcare research and clinical trials—supporting studies on Government Programs, Vaccines, Cell & Gene Therapy, Ophthalmology, Neuroscience, and Rare Diseases. In line with the theme of Naya Bharat (New India), and together with Veridix’s AI-first model, we are working to make drug development more efficient, strengthen healthcare systems, and promote equitable global health. Subhrajit Ghose, Manjunath Shanabag, Dhanalakshmi K
-
-
We are proud to share that Emmes expert Mel Bowman, MS contributed to this newly published JAMA Oncology article on COVID-19 risks in cancer patients. The NCCAPS study highlights key factors linked to hospitalization and mortality—and the protective effect of vaccination. Read the full article: https://hubs.la/Q03BFyVz0 #Emmes #OncologyResearch #COVID19 #CancerCare #JAMAOncology
-
Congratulations to Christine Orndahl, PhD, Caroline Nyaiburi, Maria Abraham, and Keri Fullmer Hammel, part of the Emmes ophthalmology team, for their contributions to a newly published study on retinal sensitivity in age-related macular degeneration. The research reveals sharp functional declines near geographic atrophy lesion borders—providing valuable insights for clinical trial design and endpoint evaluation in AMD. Read the full article: https://lnkd.in/eFA3FF66 #Emmes #Ophthalmology #AMD #GeographicAtrophy #ClinicalTrials #VisionResearch
-
It’s been an incredible experience for the Emmes team at #MHSRS2025— connecting, learning, and sharing our passion for advancing military health research. We’ve had great conversations with DHA, USAMRDC, and representatives from public-private partnerships exploring collaboration in neuroscience, including TBI, PTSD, chronic pain, and substance use disorder. We’re proud to be part of the mission to advance innovation in these critical areas. #Emmes #MHSRS #MilitaryHealth #ClinicalResearch #Neuroscience #TBI #PTSD #ChronicPain #SubstanceUseDisorder
-
-
Advancing Ophthalmology Through Innovation! In one of our most complex ophthalmology studies to date, Emmes delivered full-service support for a multi-year, international Phase II trial targeting Geographic Atrophy (GA) due to AMD—one of the leading causes of vision loss. Faced with major hurdles like placebo manufacturing disruptions, we responded with agility and innovation. The result? A published study in the National Library of Medicine (NLM) that not only advanced our understanding of GA, but also showcased Emmes' ability to deliver resilient, global clinical research solutions. Read the case study and explore our work in ophthalmology: #Ophthalmology #ClinicalResearch #AMD #GeographicAtrophy #TrialDesign #InnovationInTrials #Emmes
-
Emmes is at MHSRS 2025! With 650+ infectious disease and 180+ neuroscience trials, and powerful AI tools from our Veridix, part of Emmes Group unit, Emmes brings science, operations, and innovation together to advance military and public health research. Stop by Booth 615 to meet the team and learn more. #MHSRS2025 #WarfighterHealth #Emmes #DefenseInnovation #HealthResearch #CRO #ClinicalResearch
-